We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

917 hedge funds and large institutions have $44.1B invested in Thermo Fisher Scientific in 2014 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 329 increasing their positions, 365 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more call options, than puts

Call options by funds: $188M | Put options by funds: $114M

26% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 50

16% more funds holding in top 10

Funds holding in top 10: 5867 (+9)

2% more capital invested

Capital invested by funds: $43.2B → $44.1B (+$891M)

1% more funds holding

Funds holding: 911917 (+6)

10% less repeat investments, than reductions

Existing positions increased: 329 | Existing positions reduced: 365

1.57% less ownership

Funds ownership: 92.53%90.96% (-1.6%)

Holders
917
Holders Change
+6
Holders Change %
+0.66%
% of All Funds
26.6%
Holding in Top 10
67
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+15.52%
% of All Funds
1.94%
New
63
Increased
329
Reduced
365
Closed
50
Calls
$188M
Puts
$114M
Net Calls
+$74M
Net Calls Change
+$6.14M
Name Holding Trade Value Shares
Change
Change in
Stake
NAM
601
North American Management
Massachusetts
$1.13M
ANRIA
602
American National Registered Investment Advisor
Texas
$1.13M -$4.13K -34 -0.4%
Creative Planning
603
Creative Planning
Kansas
$1.13M +$172K +1,418 +18%
GLA
604
Great Lakes Advisors
Illinois
$1.12M +$599K +4,930 +115%
SI
605
Stephens Inc
Arkansas
$1.11M +$240K +1,976 +28%
JG
606
Jefferies Group
New York
$1.11M -$5.24M -43,056 -82%
Mariner
607
Mariner
Kansas
$1.1M +$636K +5,228 +138%
ID
608
Integral Derivatives
New York
$1.1M +$386K +3,175 +54%
EOJOAM
609
E. Ohman J:or Asset Management
Sweden
$1.1M +$146K +1,200 +15%
BVDMP
610
Bedrijfstakpensioenfonds Voor De Media PNO
Netherlands
$1.09M
WT
611
Whittier Trust
California
$1.08M -$26.7K -220 -2%
Verition Fund Management
612
Verition Fund Management
Connecticut
$1.07M +$171K +1,403 +19%
SACTSONJ
613
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$1.07M
CYG
614
Clean Yield Group
Vermont
$1.07M -$274K -2,254 -20%
CTC
615
Central Trust Company
Missouri
$1.07M +$463K +3,808 +77%
CSS
616
Cubist Systematic Strategies
Connecticut
$1.06M -$3.64M -29,947 -77%
MNBTD
617
Moody National Bank Trust Division
Texas
$1.06M -$28.5K -234 -3%
NAM
618
NTV Asset Management
West Virginia
$1.06M
ASN
619
Advisory Services Network
Georgia
$1.05M +$7.78K +64 +0.7%
CCS
620
Crosspoint Capital Strategies
California
$1.04M +$13.6K +112 +1%
RJT
621
Raymond James Trust
Florida
$1.04M -$70.9K -583 -6%
WJA
622
Williams Jones & Associates
New York
$1.03M -$106K -871 -9%
Capital Fund Management (CFM)
623
Capital Fund Management (CFM)
France
$1.02M +$1.02M +8,426 New
DIA
624
Denver Investment Advisors
Colorado
$1.02M +$1.02M +8,358 New
NCM
625
Novare Capital Management
North Carolina
$988K

TMO Hedge Fund Activity: Q3 2014 in Review

917 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2014, worth a combined $44.1B — up 2.1% from $43.2B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new TMO positions and 50 closed out — a net gain of 13 holders — while 329 added to existing stakes and 365 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $288M. The largest seller was Paulson & Co, exiting entirely with an estimated $381M sold.

  • 917 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2014, up from 911 in Q2 2014.
  • Funds reported $44.1B of Thermo Fisher Scientific stock for Q3 2014, up 2.1% quarter-over-quarter.
  • 63 funds opened new Thermo Fisher Scientific positions in Q3 2014 and 50 closed out, a net change of +13 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2014 was Wellington Management Group, an estimated $288M added.
  • The largest Thermo Fisher Scientific seller in Q3 2014 was Paulson & Co, an estimated $381M sold.

Based on aggregated 13F filings for Q3 2014.